HCA Healthcare Allocates $100 Million in Grants from the HCA Healthcare Hope Fund to Assist Needy Colleagues
HCA Healthcare, Inc. (NYSE:HCA), a prominent healthcare provider in the United States, has announced that its HCA Healthcare Hope Fund, a 501(c)3 public charity offering emergency aid to colleagues facing significant hardships such as illness, injury, natural disasters, or other…
MEDITECH Receives Best in KLAS Recognition for the 10th Straight Year
For the fifth year running, MEDITECH’s Expanse platform maintains its dominant position at the forefront of the KLAS leaderboard. In the 2024 Best in KLAS: Software & Services report, Expanse has secured the top rank for Acute Care EHR: Small…
Forecast 2023-2028: Strong Growth Expected in Global Fetal Doppler Market Driven by Increased At-Home Utilization and Technological Advancements
The ResearchAndMarkets.com platform now includes the “Fetal Doppler Market – Global Outlook & Forecast 2023-2028” report in its offerings. The global fetal Doppler market is poised for significant advancement driven by heightened at-home usage, integration with mobile apps, and a…
Relatient Recognized as Best in KLAS for Patient Self-Scheduling by KLAS Research
Relatient, a premier patient scheduling platform, has clinched the top spot as the Best in KLAS patient self-scheduling solution according to KLAS Research. This prestigious recognition stems from extensive feedback gathered from thousands of providers over the course of 2023.…
Viz.ai Corrects and Replaces Announcement: Viz™ Neuro Suite’s Impact on Patient Care Validated by Six Clinical Studies
The second sentence of the first paragraph of the release should read: “Six studies, presented at the International Stroke Conference (ISC) 2024, have shown positive outcomes with real-world impact of Viz.ai in clinical practice across various neurology pathologies including acute…
Delta-Fly Pharma Inc. Submits Abstracts for Phase I Clinical Trial of DFP-14927 to the 2024 ASCO Annual Meeting
Following our previous update on January 5, 2024, we are delighted to share the latest advancements with you. A Phase I dose-ranging clinical trial investigating DFP-14927 in patients with solid tumors has been successfully conducted at MD Anderson Cancer Center…
Enanta Pharmaceuticals Announces Fiscal First Quarter Financial Results for December 31, 2023, Hosting Webcast and Conference Call Today at 4:30 p.m. ET
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology firm specializing in small molecule drugs within virology and immunology, has released its financial results for the fiscal first quarter ending December 31, 2023. The company’s President and Chief Executive Officer, Jay…
Healthmine Welcomes Maureen Sullivan, Former Executive at Blue Cross Blue Shield Association, to Advisory Board
Healthmine Welcomes Maureen Sullivan, Former Chief Strategy and Innovation Officer at Blue Cross Blue Shield Association, to Advisory Board Healthmine, a pioneer in technology-driven member engagement solutions, proudly announces the addition of Maureen Sullivan, President of Balestrand Strategic Advisors, to…
UniCare Rebrands as Wellpoint
UniCare Rebrands as Wellpoint to Emphasize Whole Health Mission UniCare, a health benefits administrator serving over 200,000 Massachusetts state and municipal employees, retirees, and their families, is undergoing a rebranding initiative starting today. The company will now be known as…
BGB Group Collaborates with Scrum50 to Provide Impactful, Consumer-Focused Creative Solutions to Healthcare Clients
BGB Group (BGB), a distinguished healthcare commercialization and communications firm headquartered in New York City with additional offices in Washington DC, Boston, and London, has revealed a strategic partnership with Scrum50 (S50). Scrum50, a dynamic and agile-first creative agency located…
US Demonstrates Clinical Effectiveness of FEops AI-Enhanced Predictive Pre-planning for Left Atrial Appendage Occlusion (LAAO)
Data from the inaugural US-wide single-center experience at St. Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session during the AF Symposium 2024 in Boston, demonstrates that Left Atrial Appendage Occlusion (LAAO) procedures, strategically planned using FEops…
FDA Grants Approval to Edwards’ EVOQUE Valve Replacement System, Marking a Milestone as the First Transcatheter Therapy for Tricuspid Valve
Edwards Lifesciences Corporation (NYSE: EW) has announced the FDA approval of its EVOQUE tricuspid valve replacement system, marking a groundbreaking achievement as the first transcatheter therapy authorized for treating tricuspid regurgitation (TR) in the United States. The EVOQUE system is…